🕵️ Agomab Therapeutics NV ($AGMB)
SEC insider & ownership activity, last 12 months · CIK 2020932 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| LSP 7 Management B.V. | 10.6% | 13D | Feb 9, 2026 | filing ↗ | |
| LSP 7 Cooperatieve U.A. | 10.6% | 13D | Feb 9, 2026 | filing ↗ | |
| FMR LLC | 10.0% | 13G | Mar 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.0% | 13G | Mar 6, 2026 | filing ↗ | |
| Pontifax Vi G.p. L.p. | 6.8% | 13G | Apr 16, 2026 | filing ↗ | |
| Pontifax Management 4 G.P. (2015) Ltd. | 6.8% | 13G | Apr 16, 2026 | filing ↗ | |
| Ran Nussbaum | 6.8% | 13G | Apr 16, 2026 | filing ↗ | |
| Tomer Kariv | 6.8% | 13G | Apr 16, 2026 | filing ↗ | |
| Sanofi | 5.7% | 13G | May 6, 2026 | filing ↗ | |
| Redmile Group, LLC | 5.6% | 13G | May 15, 2026 | filing ↗ | |
| Jeremy C. Green | 5.6% | 13G | May 15, 2026 | filing ↗ | |
| Redmile Biopharma Investments III, L.P. | 5.6% | 13G | May 15, 2026 | filing ↗ | |
| Cormorant Asset Management, LP | 5.0% | 13G | May 15, 2026 | filing ↗ | |
| Bihua Chen | 5.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.